首页> 外文OA文献 >PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia
【2h】

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia

机译:精神分裂症最近诊断和慢性病的精神病超高风险个体推定小胶质细胞激活的pET成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

We examined putative microglial activation as a function of illness course in schizophrenia. Microglial activity was quantified using [11C](R)-(1-[2-chrorophynyl]-N-methyl-N-[1-methylpropyl]-3 isoquinoline carboxamide (11C-(R)-PK11195) positron emission tomography (PET) in: (i) 10 individuals at ultra-high risk (UHR) of psychosis; (ii) 18 patients recently diagnosed with schizophrenia; (iii) 15 patients chronically ill with schizophrenia; and, (iv) 27 age-matched healthy controls. Regional-binding potential (BPND) was calculated using the simplified reference-tissue model with four alternative reference inputs. The UHR, recent-onset and chronic patient groups were compared to age-matched healthy control groups to examine between-group BPND differences in 6 regions: dorsal frontal, orbital frontal, anterior cingulate, medial temporal, thalamus and insula. Correlation analysis tested for BPND associations with gray matter volume, peripheral cytokines and clinical variables. The null hypothesis of equality in BPND between patients (UHR, recent-onset and chronic) and respective healthy control groups (younger and older) was not rejected for any group comparison or region. Across all subjects, BPND was positively correlated to age in the thalamus (r=0.43, P=0.008, false discovery rate). No correlations with regional gray matter, peripheral cytokine levels or clinical symptoms were detected. We therefore found no evidence of microglial activation in groups of individuals at high risk, recently diagnosed or chronically ill with schizophrenia. While the possibility of 11C-(R)-PK11195-binding differences in certain patient subgroups remains, the patient cohorts in our study, who also displayed normal peripheral cytokine profiles, do not substantiate the assumption of microglial activation in schizophrenia as a regular and defining feature, as measured by 11C-(R)-PK11195 BPND.
机译:我们研究了精神分裂症中假定的小胶质细胞活化与疾病进程的关系。小胶质细胞活性使用[11C](R)-(1- [2-chrorophynyl] -N-甲基-N- [1-甲基丙基] -3异喹啉羧酰胺(11C-(R)-PK11195)正电子发射断层扫描(PET)进行定量):(i)10位精神病超高危(UHR)患者;(ii)最近被诊断出患有精神分裂症的18位患者;(iii)患有精神分裂症的慢性病患者;以及(iv)27位年龄相匹配的健康对照。使用简化的参考组织模型和四个替代参考输入来计算区域结合潜力(BPND),将UHR,近期发病和慢性患者组与年龄匹配的健康对照组进行比较,以检查两组之间的BPND差异。 6个区域:背额,​​眼眶额,前扣带回,颞内侧,丘脑和孤立岛。检验了灰质体积,外周细胞因子和临床变量与BPND关联的相关分析。患者之间BPND相等的零假设(UHR,近期发病和慢性)和各自的所有对照组(年轻人和老年人)均未因任何组比较或区域而被拒绝。在所有受试者中,BPND与丘脑年龄呈正相关(r = 0.43,P = 0.008,错误发现率)。未发现与区域灰质,外周细胞因子水平或临床症状相关。因此,我们没有发现在高危人群中,最近被诊断出或患有慢性精神分裂症的个体中小胶质细胞活化的证据。尽管某些患者亚组中11C-(R)-PK11195结合差异的可能性仍然存在,但我们研究中的患者队列也显示出正常的外周细胞因子谱,并未证实精神分裂症中小胶质细胞活化的假设是正常且确定的由11C-(R)-PK11195 BPND测量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号